Browse > Article
http://dx.doi.org/10.4014/jmb.1806.06004

Combined Lowering Effects of Rosuvastatin and L. acidophilus on Cholesterol Levels in Rat  

Wang, Lijun (Department of Cardiology, Affiliated Zhongshan Hospital, Dalian University)
Zhou, Baihua (Department of Cardiology, Affiliated Zhongshan Hospital, Dalian University)
Zhou, Xue (Department of Laboratory, The Second Affiliated Hospital of Jiaxing University, Jiaxing Second Hospital)
Wang, Yang (Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University)
Wang, Hongwei (Department of Cardiology, Affiliated Zhongshan Hospital, Dalian University)
Jia, Shengying (Department of Cardiology, Affiliated Zhongshan Hospital, Dalian University)
Zhang, Zhipeng (Department of Cardiology, Affiliated Zhongshan Hospital, Dalian University)
Chu, Chao (Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University)
Mu, Jianjun (Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University)
Publication Information
Journal of Microbiology and Biotechnology / v.29, no.3, 2019 , pp. 473-481 More about this Journal
Abstract
Statins are a class of lipid-lowering drugs commonly used in the prevention of cardiovascular diseases. However, statin therapy presents many limitations, which have led to an increased interest in non-drug therapies, such as probiotics, to improve blood cholesterol levels. Indeed, probiotic strains such as Lactobacillus acidophilus have been found to improve blood lipid profiles, especially in reducing total cholesterol and LDL-C levels. In this study, we established a high-cholesterol rat model and studied the effect of Lactobacillus acidophilus administration alone or in combination with rosuvastatin. We were able to show that Lactobacillus exerts a cholesterol-lowering effect. Additionally, we observed that when administered together, rosuvastin and Lactobacillus exert a combined cholesterol-lowering effect. Altogether, our data advocate for the possibility of establishing probiotics as non-drug supplements for the treatment of hypercholesterolemia.
Keywords
Lactobacillus acidophilus; rosuvastatin; cholesterol; hypercholesterolemia; cardiovascular disease;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Liu Y, Zhao F, Liu J, Wang H, Han X, Zhang Y, et al. 2017. Selection of cholesterol-lowering lactic acid bacteria and its effects on rats fed with high-cholesterol diet. Curr. Microbiol. 74: 623-631.   DOI
2 Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, et al. 2011. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 94: 3288-3294.   DOI
3 Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. Lipids Health Dis. 10: 126.   DOI
4 Bahekar AA, Singh S, Saha S, Molnar J, Arora R. 2007. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am. Heart J. 154: 830-837.   DOI
5 Begley M, Hill C, Gahan CG. 2006. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72: 1729-1738.   DOI
6 Park YH, Kim JG, Shin YW, Kim SH, Whang KY. 2007. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J. Microbiol. Biotechnol. 17: 655-662.
7 Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284: 1365-1368.   DOI
8 Teh SS, Ahmad R, Wan-Abdullah WN, Liong MT. 2009. Evaluation of agrowastes as immobilizers for probiotics in soy milk. J. Agric. Food Chem. 57: 10187-10198.   DOI
9 Shimizu M, Hashiguchi M, Shiga T, Tamura HO, Mochizuki M. 2015. Meta-analysis: effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals. PLoS One 10: e0139795.   DOI
10 Huang Y, Zheng Y. 2010. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Br. J. Nutr. 103: 473-478.   DOI
11 Stone NJ, Robinson JG, Lichtenstein A. 2014. N. Engl. J. Med. 370: 1957.   DOI
12 Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K. 2000. Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber. J. Nutr. 130: 2151-2156.   DOI
13 Gilliland SE, Nelson CR, Maxwell C. 1985. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49: 377-381.   DOI
14 Liong MT, Shah NP. 2005. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci. 88: 55-66.   DOI
15 Huang Y, Wang J, Quan G, Wang X, Yang L, Zhong L. 2014. Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice. Appl. Environ. Microbiol. 80: 7496-7504.   DOI
16 Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias]. Kardiol. Pol. 74: 1234-1318.   DOI
17 Cosin Sales J, Fuentes Jimenez FJ, Mantilla Morato T, Ruiz E, Becerra V, Aceituno S, et al. 2015. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain]. Clin. Investig. Arterioscler. 27: 228-238.
18 Holecki M, Handzlik-Orlik G, Almgren-Rachtan A, Dulawa J, Chudek J. 2017. The decreased achievement of therapeutic goal in lipid lowering therapy in obese and diabetic patients in Poland. Pharmacol. Rep. 69: 6-12.   DOI
19 Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, et al. 2016. EUROASPIRE IV: a european society of cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 european countries. Eur. J. Prev. Cardiol. 23: 636-648.   DOI
20 Fei L, Zhang J, Niu H, Yuan C, Ma X. 2016. Effects of rosuvastatin and MiR-126 on myocardial injury induced by acute myocardial infarction in rats: role of vascular endothelial growth factor A (VEGF-A). Med. Sci. Monit. 22: 2324-2334.   DOI
21 Kunze A, Huwyler J, Camenisch G, Poller B. 2014. Prediction of organic anion-transporting polypeptide 1B1-and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data. Drug Metab. Dispos. 42: 1514-1521.   DOI
22 Zhao MM, Li D, Li Y. 2015. [Regulation of organic anion transporting polypeptides expression and activity]. Yao Xue Xue Bao 50: 400-405.
23 Le Vee M, Jouan E, Stieger B, Lecureur V, Fardel O. 2011. Regulation of drug transporter expression by oncostatin M in human hepatocytes. Biochem. Pharmacol. 82: 304-311.   DOI
24 Martinez I, Wallace G, Zhang C, Legge R, Benson AK, Carr TP, et al. 2009. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl. Environ. Microbiol. 75: 4175-4184.   DOI
25 Valerio MG, Velayati A, Jain D, Aronow WS. 2016. Promising new therapies for the treatment of hypercholesterolemia. Expert. Opin. Biol. Ther. 16: 609-618.   DOI
26 Wang P. 2011. Statin dose in Asians: is pharmacogenetics relevant? Pharmacogenomics 12: 1605-1615.   DOI
27 Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76: 1249-1255.   DOI
28 Wang IK, Wu YY, Yang YF, Ting IW, Lin CC, Yen TH, et al. 2015. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef. Microbes. 6: 423-430.   DOI
29 Karamese M, Aydin H, Sengul E, Gelen V, Sevim C, Ustek D, et al. 2016. The immunostimulatory effect of lactic acid bacteria in a rat model. Iran J. Immunol. 13: 220-228.
30 Yasuda SU, Zhang L, Huang SM. 2008. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin. Pharmacol. Ther. 84: 417-423.   DOI
31 Cardiometabolic Risk Working Group: Executive C, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, et al. 2011. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can. J. Cardiol. 27: e1-e33.   DOI
32 Guglielmi V, Bellia A, Pecchioli S, Della-Morte D, Parretti D, Cricelli I, et al. 2017. Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: a real-world evidence study in primary care. Atherosclerosis 263: 36-41.   DOI
33 Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, et al. 2008. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin. Ther. 30: 2167-2179.   DOI
34 Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, et al. 2014. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J. Am. Coll. Cardiol. 63: 2960-2984.   DOI
35 Dattilo AM, Kris-Etherton PM. 1992. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am. J. Clin. Nutr. 56: 320-328.   DOI
36 Townsend N, Nichols M, Scarborough P, Rayner M. 2015. Cardiovascular disease in Europe 2015: epidemiological update. Eur. Heart J. 36: 2673-2674.
37 Zheng Y, Lu Y, Wang J, Yang L, Pan C, Huang Y. 2013. Probiotic properties of Lactobacillus strains isolated from Tibetan kefir grains. PLoS One 8: e69868.   DOI
38 Huang Y, Wang J, Cheng Y, Zheng Y. 2010. The hypocholesterolaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-like 1. Br. J. Nutr. 104: 807-812.   DOI
39 Consonni A, Cordiglieri C, Rinaldi E, Marolda R, Ravanelli I, Guidesi E, et al. 2018. Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats. Oncotarget 9: 22269-22287.   DOI
40 Gerhard D, Sousa F, Andraus RAC, Pardo PE, Nai GA, Neto HB, et al. 2017. Probiotic therapy reduces inflammation and improves intestinal morphology in rats with induced oral mucositis. Braz. Oral Res. 31: e71.
41 Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. 2010. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5: e10667.   DOI
42 Kato T, Fukuda S, Fujiwara A, Suda W, Hattori M, Kikuchi J, et al. 2014. Multiple omics uncovers host-gut microbial mutualism during prebiotic fructooligosaccharide supplementation. DNA Res. 21: 469-480.   DOI
43 Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7: 335-336.   DOI
44 Brown L, Rosner B, Willett WW, Sacks FM. 1999. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am. J. Clin. Nutr. 69: 30-42.   DOI
45 McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. 2012. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6: 610-618.   DOI
46 Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73: 5261-5267.   DOI
47 Huffman KM, Hawk VH, Henes ST, Ocampo CI, Orenduff MC, Slentz CA, et al. 2012. Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in studies of a targeted risk reduction intervention through defined exercise I. Am. Heart J. 164: 117-124.   DOI
48 Kelley GA, Kelley KS. 2009. Impact of progressive resistance training on lipids and lipoproteins in adults: another look at a meta-analysis using prediction intervals. Prev. Med. 49: 473-475.   DOI
49 Shaw K, Gennat H, O'Rourke P, Del Mar C. 2006. Exercise for overweight or obesity. Cochrane Database Syst. Rev. 4: CD003817.
50 Gylling H, Plat J, Turley S, Ginsberg HN, Ellegard L, Jessup W, et al. 2014. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis 232: 346-360.   DOI
51 Hollaender PL, Ross AB, Kristensen M. 2015. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. Am. J. Clin. Nutr. 102: 556-572.   DOI
52 Musa-Veloso K, Poon TH, Elliot JA, Chung C. 2011. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebocontrolled trials. Prostaglandins Leukot Essent Fatty Acids 85: 9-28.   DOI
53 Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM. 1999. Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: a metaanalysis. Am. J. Clin. Nutr. 69: 632-646.   DOI
54 Russo M, Fabersani E, Abeijon-Mukdsi MC, Ross R, Fontana C, Benitez-Paez A, et al. 2016. Lactobacillus fermentum CRL1446 ameliorates oxidative and metabolic parameters by increasing intestinal feruloyl esterase activity and modulating microbiota in caloric-restricted mice. Nutrients 8.
55 Rudling M. 1992. Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J. Lipid. Res. 33: 493-501.   DOI
56 Wilson MD, Rudel LL. 1994. Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J. Lipid. Res. 35: 943-955.   DOI
57 Tung YC, Lin YH, Chen HJ, Chou SC, Cheng AC, Kalyanam N, et al. 2016. Piceatannol exerts anti-obesity effects in C57BL/6 mice through modulating adipogenic proteins and gut microbiota. Molecules 21.
58 Catry E, Pachikian BD, Salazar N, Neyrinck AM, Cani PD, Delzenne NM. 2015. Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sci. 132: 77-84.   DOI
59 Jasso-Padilla I, Juarez-Flores B, Alvarez-Fuentes G, De la Cruz-Martinez A, Gonzalez-Ramirez J, Moscosa-Santillan M, et al. 2017. Effect of prebiotics of Agave salmiana fed to healthy Wistar rats. J. Sci. Food Agric. 97: 556-563.   DOI
60 Xie N, Cui Y, Yin YN, Zhao X, Yang JW, Wang ZG, et al. 2011. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement. Altern. Med. 11: 53.   DOI
61 Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Labbe A, Rodes L, et al. 2014. Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Appl. Microbiol. Biotechnol. 98: 115-126.   DOI
62 Keys A. 1984. Serum cholesterol response to dietary cholesterol. Am J Clin Nutr. 40: 351-359.   DOI